The traditional use of southern African medicinal plants in the treatment of viral respiratory diseases: A review of the ethnobotany and scientific evaluations

Abstract

Ethnopharmacological relevance Viral respiratory infections are amongst the most common infections globally, with most of the world's population contracting at least one infection annually. Numerous plant species are used in traditional southern African healing systems to treat these diseases and to alleviate the symptoms. Despite this, the therapeutic potential of these plants against viral respiratory diseases remains poorly explored. Aim of the study The aim of this study was to document the southern African plant species used in traditional medicine to treat viral respiratory infections. We also examined the extent of scientific evaluations of southern African plant species against the respiratory-infective viruses, with the aim of stimulating interest in this area and focusing on future studies. Materials and methods We undertook an extensive review of ethnobotanical books, reviews and primary scientific studies to identify southern African plants which are used in traditional southern African medicine to treat viral respiratory diseases. This information was used to identify gaps in the current research that require further study. Results Two hundred and fifty-seven southern African plant species were identified as traditional therapies for viral respiratory diseases. Surprisingly, only one of those species (as well as twenty-one other species not recorded for these purposes) has been evaluated for the ability to block respiratory virus production. Furthermore, most of these studies screened against a single viral strain and none of those studies examined the mechanism of action of the plant preparations. Conclusions Despite well documented records of the use of southern African plants to treat respiratory viral diseases, the field is poorly explored. Nearly all of the plant species used in traditional healing systems to treat these diseases are yet to be tested. Substantial further work is required to verify the efficacy of these traditional medicines.

Medicinal Plants for Mitigating Pain and Inflammatory-Related Conditions: An Appraisal of Ethnobotanical Uses and Patterns in South Africa

“…The current observation whereby the leaves were the dominant plant part remains a common pattern as evident in the recent appraisal of ethnobotanical surveys in southern Africa (Semenya and Maroyi 2018;Ndhlovu et al, 2021). Particularly, the leaves were the most frequently used plant part for the treatment of bacterial (Cock and Van Vuuren 2020a) and viral (Cock and Van Vuuren 2020b) respiratory infections across the traditional southern African healing systems. On a global scale, Aumeeruddy and Mahomoodally (2020) identified leaves as the most used plant part in the management of hypertension in traditional medicine.…”

Flavonoids from Siparuna cristata as Potential Inhibitors of SARS-CoV-2 Replication

“…According to "Diagnosis and Treatment Program for Corona Virus Disease 2019 (COVID-19)" in China, treatment with traditional medicine is recommended, which has achieved good clinical effects (Ren et al 2020). In the same way, a recent work (Cock and Vuuren 2020) revealed the potential of South African medicinal plants used to treat viral respiratory diseases in screening studies against the SARS-CoV-2 virus. Brazil has a long tradition of medicinal plant use, and in many regions of the country where medical care units are scarce or inexistent, traditional medicinal therapies are the only option which is being used to overcome COVID-19.…”

The 2020 Coronavirus (COVID-19) Global Pandemic, a Call to Arms to Pharmacognosy Researchers – Plant-Based Antiviral Approaches

“…Pharmacognosy offers a wide range of parent molecules for development of new target agents, with existing agents demonstrating antiviral properties in different contexts. 2,21,40,[44][45][46][47][48][49][50][51][52][53][54][55][56] The faster time to market of these agents may provide a valuable asset in this race to novel drug discovery. 57 Key challenges that pharmacognosy may be able to assist in: 1.…”

“…The lack of lead discovery conducted on this and other traditional medicine systems indicates an untapped repository of ethnobotanical data that may be crucial in the rapid discovery of new drugs. 46,[58][59][60] During previous coronavirus outbreaks, plant-based agents were identified with in vitro activity against coronavirus species. However the transient short lived nature of these events limited the progression of these compounds to in vivo trials.…”